Statins vs. Fibrates: Which Is Better for Managing Cholesterol and Triglycerides?
- Statins lower high LDL, while fibrates lower high triglyceride levels.
- Statins work by blocking a liver enzyme that is responsible for making cholesterol. Fibrates work by activating a protein that helps the body break down fats more effectively.
- Statins are the first-line treatment to reduce the risk of heart attacks and strokes. Fibrates are useful when high triglycerides or low HDL are the primary concerns.
- Lp(a) is another type of fat-carrying particle that can increase the risk of heart disease and blood clots. Unlike other cholesterol types, Lp(a) levels are largely determined by genetics and not easily changed by diet or exercise.
- Fibrates may have a greater effect on lowering Lp(a) compared to statins, according to some research.
High cholesterol and high triglycerides are two common problems that increase your risk of heart disease, stroke, and other serious conditions. When diet and exercise aren't enough to lower these levels, medications are necessary. Two of the most common classes of medications are statins and fibrates.
Statins are widely prescribed due to their effectiveness in lowering LDL and reducing the risk of heart attacks and strokes. They work by blocking an enzyme in the liver responsible for cholesterol production, leading to significant reductions in LDL levels.
On the other hand, fibrates are mainly used to lower triglycerides and increase HDL. They activate specific proteins that help break down fats in the body, making them suitable for patients with high triglycerides or low HDL levels.
Understanding how these medications work and their specific uses can help you make informed decisions about your treatment plan.
How They Work
Both fibrates and statins are medications that help manage fats (lipids) in your blood, but they do so in different ways. Fibrates focus on lowering triglycerides and raising good cholesterol, while statins work by reducing the amount of cholesterol your liver makes.
How do Fibrates Work?
Fibrates are primarily used to improve how your body processes fats in your blood. Think of fibrates as turning on a special "fat-processing switch" inside your liver and muscle cells. This switch is a protein called PPAR-alpha. When fibrates activate PPAR-alpha, several helpful things happen:
- Breaking down triglycerides more quickly: Fibrates boost the action of lipoprotein lipase (LPL), an enzyme that helps remove triglycerides from your blood.
- Reducing triglyceride production: Your liver slows down its production of fatty acids that form triglycerides, resulting in less circulating fat.
- Increasing HDL cholesterol: Fibrates help your body produce more of the building blocks (apolipoproteins A-I and A-II) for HDL cholesterol. HDL helps remove excess fat from your blood vessels.
- Lowering VLDL levels: Very-low-density lipoprotein (VLDL) carries triglycerides. Fibrates reduce the amount of VLDL produced in your liver.
- Little change in LDL: Fibrates don't significantly lower LDL cholesterol, the main type that contributes to artery plaque. However, they can make LDL particles less dense, potentially making them less harmful.
How do Statins Work?
Statins are used to lower LDL levels by slowing down cholesterol production in the liver. Think of statins as putting a brake on your liver's cholesterol-making machinery. They target a specific enzyme called HMG-CoA reductase, which is essential for your liver to produce cholesterol. By blocking this enzyme, statins cause your liver to:
- Produce less cholesterol: The overall production of cholesterol in your liver slows down.
- Remove more cholesterol from the Blood: To compensate for the reduced production, your liver pulls more cholesterol out of your bloodstream. This leads to lower levels of LDL cholesterol.
The result of this action is:
- Less artery plaque: With less cholesterol in your blood, less of it can build up in the walls of your arteries.
- Lower risk of heart problems: This reduction in plaque buildup lowers your risk of heart attack and stroke.
Statins also lower triglyceride levels and help raise HDL cholesterol, making your overall lipid profile healthier.
Uses
When Are Fibrates Used?
Fibrates are prescrobed for patients with high triglycerides or low HDL cholesterol, and can also be considered for patients with high cholesterol when other treatments have not worked well enough.
According to the FDA, fibrates are approved for the following:
- Primary hypercholesterolemia or mixed dyslipidemia: High levels of LDL cholesterol, or a combination of high LDL and high triglycerides, which can increase your risk of heart disease if left untreated.
- Severe hypertriglyceridemia: Very high triglyceride levels in your blood, which can increase your risk of pancreatitis (inflammation of your pancreas).
What Results Can You Expect with Fibrates?
Fibrates can have varying effects from person to person, but studies show that certain fibrates (like fenofibrate and gemfibrozil) can typically lead to:
- Up to a 50% drop in triglyceride levels
- About a 20% increase in HDL cholesterol
- Around a 10% reduction in total cholesterol
Even small improvements in these numbers can lead to a lower risk of heart attack, stroke, and other complications, especially when used alongside healthy eating and exercise.
In less common cases, fibrates may be used off-label for primary biliary cholangitis, a rare liver condition, though this is not an FDA-approved use.
What are statins used for?
Statins are FDA-approved for the following conditions:
- Reducing Cardiovascular Risk: Lowering the risk of heart attack, stroke, and other heart-related events in adults at high risk (including those with diabetes, high blood pressure, or a family history of cholesterol problems).
- Lowering High Cholesterol and Triglycerides: Reducing elevated levels of LDL cholesterol and triglycerides.
Statins are almost always used alongside a healthy diet and lifestyle changes. They’re not a substitute for healthy habits, but they can play a major role in preventing serious heart problems.
What Results Can You Expect with Statins?
Statins vary in how strongly they lower LDL cholesterol. This is why they’re grouped into three intensity levels:
- High-Intensity Statins
- Can reduce LDL levels by more than 50%.
- These are the strongest and typically prescribed for individuals at the highest risk (e.g., those who've had a heart attack or stroke, or have very high LDL).
- Moderate-Intensity Statins
- Can reduce LDL by 30-49%.
- Used when strong LDL lowering isn't needed or when higher doses aren't tolerated.
- Low-Intensity Statins
- Reduce LDL by less than 30%.
- Used when patients can't tolerate higher doses due to side effects like muscle aches.
Side Effects
Both statins and fibrates are generally safe for most people, but like all medications, they have potential side effects:
- Statins: Can cause muscle aches, fatigue, and, rarely, liver enzyme elevations or muscle breakdown (rhabdomyolysis).
- Fibrates: Can cause stomach discomfort, increase your risk of gallstones, and increase liver enzymes. They may also cause muscle issues, especially when used with statins.
Patients with kidney or liver problems may need dose adjustments or may not be able to take these medications at all.
Which is More Commonly Prescribed?
Statins are more commonly prescribed because they have a proven track record of effectively lowering LDL cholesterol and reducing the risk of heart attacks and strokes. They are considered the first-line treatment for high cholesterol and are often prescribed alongside lifestyle changes such as diet and exercise.
Fibrates, while effective for specific lipid abnormalities, are typically used when triglycerides are high or HDL is low, and are often prescribed in combination with statins for comprehensive lipid management.
What is Lp(a), and Why does It Matter?
When we talk about cholesterol, we usually focus on LDL, HDL, and triglycerides. However, there's another important type of fat-carrying particle in your blood called lipoprotein(a), often shortened to Lp(a). You might not hear about it as often, but it plays a role in heart health.
What is Lp(a)?
Lp(a) is similar to LDL cholesterol, but it has an extra protein attached to it called apolipoprotein(a). This extra protein makes Lp(a) stickier, increasing its tendency to attach to the walls of your blood vessels. This which can increase your risk of plaque buildup, blood clots, and heart disease.
What makes Lp(a) different from other cholesterol types is that you can’t control it with diet or exercise.
Doctors consider Lp(a) levels elevated when they are 30 mg/dL or higher. High Lp(a) has been linked to an increased risk of:
- Heart attacks
- Stroke
- Atherosclerosis (hardening of the arteries)
- Blood clots
The Role of Statins and Fibrates in Lp(a) Levels
According to a 2017 study comparing the effects of statins and fibrates, fibrates lowered Lp(a) more than statins did, especially in patients with high Lp(a) levels to begin with. This does not mean fibrates replace statins, but it shows they might be a better option when Lp(a) is part of the problem.
Talk to Your Doctor
Statins and fibrates are both used to improve cholesterol and triglyceride levels, but they work in different ways and are often prescribed for different reasons.
- Statins: Generally the first choice for lowering LDL and preventing heart attacks and strokes.
- Fibrates: Especially useful when triglycerides are high, HDL is low, or when lipoprotein(a) is elevated.
If you’ve been told your cholesterol or triglycerides are off, or if you have a family history of early heart disease, it’s worth asking your doctor whether your full lipid panel has been checked, including your Lp(a) level. Based on your results, your provider can decide whether a statin or fibrate is right for you.
References:
- Singh G, Correa R. Fibrate Medications. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 May 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547756/
- Sahebkar A, Simental-Mendía LE, Watts GF, Serban M-C, Banach M. Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials. BMC Med. 2017;15:22. doi:10.1186/s12916-017-0787-7.